価格表

在庫・価格 : 2026年04月09日 08時04分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
PDGF-DD, Human, Recombinant
データシート
1159-SB-025 RSDアールアンドディー システムズ
R&D Systems, Inc.
25 μg ¥71,000 1個 追加

在庫・価格 : 2026年04月09日 08時04分 現在

PDGF-DD, Human, Recombinant

  • 商品コード:1159-SB-025
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥71,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Rovida E et al. ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. J. Hepatol. 2008 Jan;48(1):107-15
Rovida E et al
2008/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
2 McCabe KL et al. Essential role for PDGF signaling in ophthalmic trigeminal placode induction. Development 2008 May;135(10):1863-74
McCabe KL et al
2008/01/01
Species: Chicken, Application: In Vivo, In Vivo PubMed
3 W奪gs辰ter D et al. Effects of PDGF-C and PDGF-D on monocyte migration and MMP-2 and MMP-9 expression. Atherosclerosis 2009 Feb;202(2):415-23
W奪gs辰ter D et al
2009/01/01
Application: Bioassay, Sample Type: Cell Culture PubMed
4 Ammoun S et al. Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma. Cancer Res. 2008 Jul;68(13):5236-45
Ammoun S et al
2008/01/01
Species: Human, Application: Bioassay, Whole Cells PubMed
5 Rice JW et al. Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis. Arthritis Rheum. 2008 Dec;58(12):3765-75
Rice JW et al
2008/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
6 Crawford Y et al. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 2009 Jan;15(1):21-34
Crawford Y et al
2009/01/01
Application: Western Blot Control, Sample Type: N/A PubMed
7 Liu J et al. PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer. Clin. Cancer Res. 2011 Jun;17(11):3638-48
Liu J et al
2011/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
8 Wilson TR et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 2012 Jul;487(7408):505-9
Wilson TR et al
2012/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
9 Petti LM et al. A single amino acid substitution converts a transmembrane protein activator of the platelet-derived growth factor β receptor into an inhibitor. J. Biol. Chem. 2013 Sep;288(38):27273-86
Petti LM et al
2013/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
10 Obenauf AC et al. Therapy-induced tumour secretomes promote resistance and tumour progression. Nature 2015 Apr;520(7547):368-72
Obenauf AC et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
11 Heim EN et al. Biologically active LIL proteins built with minimal chemical diversity. Proc. Natl. Acad. Sci. U.S.A. 2015 Aug;112(34):E4717-25
Heim EN et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
12 Martino MM et al. The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain. FASEB J. 2010 Dec;24(12):4711-21
Martino MM et al
2010/01/01
Application: Surface Plasmon Resonance, Sample Type: recombinant protein PubMed
13 Miller CL et al. Integrative functional genomics identifies regulatory mechanisms at coronary artery disease loci. Nat Commun 2016 Jul;7:12092
Miller CL et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    Rovida E et al. ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. J. Hepatol. 2008 Jan;48(1):107-15
    Rovida E et al
    2008/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    McCabe KL et al. Essential role for PDGF signaling in ophthalmic trigeminal placode induction. Development 2008 May;135(10):1863-74
    McCabe KL et al
    2008/01/01
  • 備考:
    Species: Chicken, Application: In Vivo, In Vivo
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    W奪gs辰ter D et al. Effects of PDGF-C and PDGF-D on monocyte migration and MMP-2 and MMP-9 expression. Atherosclerosis 2009 Feb;202(2):415-23
    W奪gs辰ter D et al
    2009/01/01
  • 備考:
    Application: Bioassay, Sample Type: Cell Culture
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Ammoun S et al. Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma. Cancer Res. 2008 Jul;68(13):5236-45
    Ammoun S et al
    2008/01/01
  • 備考:
    Species: Human, Application: Bioassay, Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Rice JW et al. Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis. Arthritis Rheum. 2008 Dec;58(12):3765-75
    Rice JW et al
    2008/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Crawford Y et al. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 2009 Jan;15(1):21-34
    Crawford Y et al
    2009/01/01
  • 備考:
    Application: Western Blot Control, Sample Type: N/A
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Liu J et al. PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer. Clin. Cancer Res. 2011 Jun;17(11):3638-48
    Liu J et al
    2011/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Wilson TR et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 2012 Jul;487(7408):505-9
    Wilson TR et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Petti LM et al. A single amino acid substitution converts a transmembrane protein activator of the platelet-derived growth factor β receptor into an inhibitor. J. Biol. Chem. 2013 Sep;288(38):27273-86
    Petti LM et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Obenauf AC et al. Therapy-induced tumour secretomes promote resistance and tumour progression. Nature 2015 Apr;520(7547):368-72
    Obenauf AC et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Heim EN et al. Biologically active LIL proteins built with minimal chemical diversity. Proc. Natl. Acad. Sci. U.S.A. 2015 Aug;112(34):E4717-25
    Heim EN et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Martino MM et al. The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain. FASEB J. 2010 Dec;24(12):4711-21
    Martino MM et al
    2010/01/01
  • 備考:
    Application: Surface Plasmon Resonance, Sample Type: recombinant protein
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Miller CL et al. Integrative functional genomics identifies regulatory mechanisms at coronary artery disease loci. Nat Commun 2016 Jul;7:12092
    Miller CL et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed